London-based health clinic for men Numan completes €11 million Series A 

Today Numan, the online health clinic for men, has completed an €11 million Series A funding round, to continue building the future of health in collaboration with its customers. The round was led by Novator, along with Anthemis Exponential, Vostok New Ventures, and Colle Capital.

Launched in February 2019, Numan helps men take action when it comes to their health and wellbeing. According to the startup, recent findings show that 3 out of 4 men don’t go to the doctor when something is wrong. Men are also more likely to get cancer, heart disease and become overweight, and are more prone to smoking, drinking, and abusing drugs. The company provides regulated treatment options for the most common male health concerns, with a team of clinicians who can create personalised treatment plans online. 

“We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems,” said Sokratis Papafloratos, Numan’s Founder and CEO. “We help men understand their health better through a series of diagnostics and clinician consultations, and offer medical solutions that cover anything from Sexual Health, to Hair Loss, Smoking Cessation and General Wellbeing – all via a comprehensive digital health platform. The COVID crisis is motivating men to take better care of themselves and we look forward to becoming a holistic health partner for them, backed by a world-class team of investors.”

As part of the funding, Birgir Már Ragnarsson joins Numan’s Board of Directors. “We were impressed with Numan’s capital-efficient execution so far and are excited about the future direction of the company. Health is one of the largest economic transformation opportunities still addressable at a global scale, and we’re delighted to be part of Numan’s journey.” 

Numan intends to use the funds to continue investing in technology, expand operations, and grow the team, with Sam Shah, ex Director of Digital Development for NHSX recently joining as Chief Medical Strategy Officer.

LEAVE A REPLY

Please enter your comment!
Please enter your name here